World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03939052
Date of registration: 01/05/2019
Prospective Registration: Yes
Primary sponsor: University of British Columbia
Public title: Protein Requirements in Adults With Phenylketonuria (PKU)
Scientific title: Protein Requirements in Phenylketonuria (PKU) Patients Compared Using PKU Sphereâ„¢ | Glycomacropeptide (GMP) and an L-amino Acid-based Product
Date of first enrolment: July 19, 2019
Target sample size: 6
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03939052
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Rajavel Elango, Ph.D
Address: 
Telephone:
Email:
Affiliation: 
Name:     Rajavel Elango, PhD
Address: 
Telephone:
Email:
Affiliation:  BC Children's Hospital Research Institute, University of British Columbia
Name:     Sandra Sirrs, MD
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Name:     Rajavel Elango, PhD
Address: 
Telephone: 604-875-2000
Email: relango@bcchr.ubc.ca
Affiliation: 
Name:     Sylvia Stockler, MD
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Key inclusion & exclusion criteria

Inclusion Criteria:

-Adults more than 19 years of age who are diagnosed with PKU and clinically stable with no
acute illness

Exclusion Criteria:

- Adults with PKU under age 19 year

- Adults diagnosed with PKU but are currently ill with a fever or cold



Age minimum: 19 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Phenylketonuria
Intervention(s)
Dietary Supplement: Free amino acids intake
Primary Outcome(s)
13 Co2 production [Time Frame: 8 hours (1 study day). 3 samples will collected as a baseline prior to isotope protocol and 6 samples after 2 hours and 30 minutes of starting the tracer protocol. Data will be reported an average of 2 years.]
Lysine flux [Time Frame: 8 hours (1 study day). 1 sample will collected as a baseline prior to isotope protocol and 2 samples after 2 hours and 30 minutes of starting the tracer protocol. Data will be reported an average of 2 years.]
Secondary Outcome(s)
Phenylalanine concentrations [Time Frame: One sample (at 6th meal) after starting of the tracer protocol. Data will be reported an average of 2 years.]
16 other amino acids [Time Frame: One sample (at 6th meal) after starting of the tracer protocol. Data will be reported an average of 2 years.]
Tyrosine concentrations [Time Frame: One sample (at 6th meal) after starting of the tracer protocol. Data will be reported an average of 2 years.]
Secondary ID(s)
H18-03464
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Vitaflo International, Ltd
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history